Table 2|.
Availability of naloxone in Pennsylvania pharmacies and pharmacy staff responses to key components of standing order for naloxone from December, 2016 to April, 2017
| Naloxone availability | N=682 | (%) |
|---|---|---|
| Pharmacies with naloxone immediately available | 306 | (45%) |
| Intranasal formulation (Narcan brand) | 202 | (30%) |
| Pre-loaded syringe with or without atomizer | 45 | (7%) |
| Auto-injector | 2 | (0%) |
| Unknown or non-specific | 10 | (1%) |
| Multiple | 47 | (7%) |
| Pharmacies without naloxone immediately available | 376 | (55%) |
| Stated that naloxone couldn’t be ordered | 140 | (21%) |
| Stated that naloxone could be ordered for pickup | 207 | (30%) |
| within 1 business day | 118 | (17%) |
| within 2 business days | 30 | (4%) |
| within 3–4 business days | 27 | (4%) |
| within 5 or more business days | 6 | (1%) |
| other or unknown | 26 | (4%) |
| Pharmacy staff member unsure whether naloxone could be ordered | 29 | (4%) |
| Pharmacy staff knowledge of naloxone standing order | N=581 | (%) |
| Standing order knowledge assessment (“Is a prescription required to obtain naloxone?”) | ||
| Correct (Answered “no”) | 373 | (64%) |
| Incorrect (Answered “yes”) | 166 | (29%) |
| Responded “I don’t know.” | 42 | (7%) |
| Third party knowledge assessment (“Can a friend, family member of someone at risk for opioid overdose obtain naloxone?”) | ||
| Correct (Answered “yes”) | 370 | (64%) |
| Incorrect (Answered “no”) | 135 | (23%) |
| Responded “I don’t know.” | 76 | (13%) |